CASP3 and glioma: The effect was significantly higher than with the administration of the same concentrations of Tubastatin A. We also found that both FRB compounds increased the number of positive cells for caspase-3 in a dose-dependent manner in the four glioma cells, revealing the accumulation of cell apoptosis (Figure 3E,F and Figure S4G–J).